Aggregator
采取多种干预为肠癌患者做好手术准备
可乐定用于慢性神经性疼痛成年人的皮肤
预防性止吐药用于急性照护环境中接受静脉阿片类药物的成年人
Xpert MTB/XDR:结核病药物耐药的快速检测
奥克莱珠单抗对多发性硬化症的益处和风险是什么?
抗生素在溃疡性结肠炎治疗中的应用
流产就诊同时或随访就诊中放置避孕植入物
理疗是否可改善成人复杂性局部疼痛综合征的疼痛和残疾?
椎动脉狭窄的血管内治疗
胸部影像诊断COVID-19的准确性如何?
胎儿手术及其他婴儿侵入性操作中给产妇及其婴儿用药来使其制动
干细胞用于治疗对克罗恩病治疗无反应的患者
妊娠14周前药物流产的疼痛管理
Featured review: Educational interventions for health professionals managing people with COPD in primary care
Watch the video of our World Health Assembly side-event on using evidence to address health challenges
Now is the time to ‘up our game’ in using evidence to address health challenges
The COVID-19 pandemic created a once-in-a-generation focus on evidence. We now have the opportunity to systematize the aspects of evidence use that are going well and to address the many gaps.
Alongside the 75th World Health Assembly, Cochrane and the Global Commission on Evidence to Address Societal Challenges co-hosted a virtual side event which brought together a global panel to discuss some of these issues.
Speakers:
- Dr Soumya Swaminathan, Chief Scientist, WHO
- Fitsum Assefa Adela, Ministry of Planning and Development, Ethiopia
- Steven J. Hoffman, member of Canada's WHA delegation; Scientific Director, CIHR Institute of Population & Public Health
- Dr Maria Endang Sumiwi, Director General of Public Health at the Ministry of Health, Indonesia
- John Lavis, Co-Lead, Evidence Commission
- Dr John Grove, Director of Quality Assurance for Norms and Standards, WHO
Co-chairs:
- Judith Brodie, Interim CEO, Cochrane
- Sylvia de Haan, Head of Advocacy, Communications and Partnerships, Cochrane
About the session
During the roundtable, leaders from WHO Member States who use evidence to guide national decision-making were encouraged to reflect on their work – and share what they need from evidence producers, evidence intermediaries, and multilateral organizations. Cochrane, the WHO Evidence-informed Policy Network and the Evidence Commission then discussed their shared vision and recommendations.
The session was a dialogue between both the demand and supply side of evidence – highlighting the key priorities for the evidence-informed future we want and need, and the conditions needed to get us there.
Related links:
Friday, May 27, 2022Featured review: Music therapy for autistic people
在牙科用抗生素预防细菌性心内膜炎(心腔内璧严重性感染或发炎)
COVID-19: Interventions to reduce the risk of coronavirus infection among workers outside healthcare settings
What is the aim of this review?
Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) can develop critical illnesses and may die, particularly older people, and those with underlying medical problems. Different interventions that attempt to prevent or reduce workers' exposure to SARS‐CoV‐2 in the workplace have been implemented during the pandemic. This Cochrane Review evaluated the effects of these interventions on the COVID‐19 infection‐rate, absenteeism, COVID‐19‐related mortality, and adverse events.
What was studied in this review?
The authors searched for studies that examined interventions according to the following four categories: 1) elimination (for example self‐isolation strategies); 2) engineering controls (for example barriers to separate or distance co‐workers, and workers from members of the public); 3) administrative controls (for example working from home); 4) personal protective equipment (for example use of face masks or other types of face covering). We included studies of any worker outside the healthcare setting. We searched for studies without language or time restrictions.
What are the main findings of this review?
The author team screened more than 13 thousand reports, and included one study, conducted in 162 secondary and post‐secondary schools in England, from March to June 2021. The study enrolled more than 24 thousand workers. In the 86 schools in the control group (standard isolation), staff who were considered COVID‐19 contacts through contact tracing were required to self‐isolate at home for 10 days. In the 76 schools in the intervention group (test‐based attendance), staff who were considered COVID‐19 contacts through contact tracing were not required to isolate. Instead, they took a daily rapid test (lateral flow antigen test) for seven days. If the rapid test was negative, the staff member could go to work. If the rapid test was positive, the staff member would self‐isolate. The researchers wanted to know if there was a difference in COVID‐related absence between the two methods.
The author team are uncertain whether a strategy of test‐based attendance changes COVID‐19 infection rates (any infection; symptomatic infection) compared with routine isolation after contact with a person with COVID‐19. COVID‐related absence may be lower or similar in the test‐based attendance group.
However, they were uncertain about these findings, because the number of infections was very low among the participants. Mortality, adverse events, quality of life, and hospitalisation were not measured. Seventy‐one per cent of the test‐based attendance group followed the strategy; the researchers did not report on compliance for the standard isolation group.
The team identified one ongoing study that also addressed the effects of screening in schools.
Another ongoing study is evaluating the effects of using a face shield to prevent COVID‐19 transmission.
The authors did not find any studies that studied engineering or administrative controls.
Matteo Bruschettini, Director of Cochrane Sweden, who led the review explains,
“Millions of scientific papers are published every year, and during the pandemic there were many about covid-19. It is not an easy task to keep up to date with the results of all these. Systematic reviews are one way of weighing up all the studies carried out in a specific field and providing an overview of the results of these studies. This review investigating how workplace interventions reduced the spread of covid-19 assessed 13, 000 scientific articles published on the subject, however only one study could be included in the review.Almost none of the studies had the study design required to answer the question of whether the effects of the intervention reduced the risk of SARS-CoV-2 infection in non-healthcare workplaces. This surprised us. These systematic reviews are important because they can provide answers to questions that are of extreme concern to millions of people in workplaces around the world.
We were able to identify two studies that had not been completed by September 2021 that may be included in the future. One assesses the benefit of face shields in preventing covid infection and the other looks at covid-19 screening in schools.”
How up‐to‐date is this review?
The author team searched for studies that were available up to 14 September 2021.
Monday, May 9, 2022